Skip to main navigation

News
Investors
Careers
Contact

About Us
Our Approach
- What We Do
- Partnering
Patients & Providers
Science & Pipeline
Investors
Careers
- Culture
- Job Openings
Contact
Home
Menu Menu

Events & Presentations

Overview
Events & Presentations
Stock Information
Press Releases
Corporate Governance
SEC Filings
- Quarterly Results
Contact
Email Alerts

Company Presentation

Zevra Corporate Presentation - March 2023

03-08-2023
Zevra Quarterly Results Presentation – Q4 and FY 2022 Results

03-07-2023

Upcoming Events

More events are coming soon.

Past Events

Year

Consero Global IP Management and IP Life Sciences Virtual Forum

06-07-2021 4:00 PM EDT

Register for webcast

KemPharm Q1 2021 Corporate Update Call

05-13-2021 4:30 PM EDT

Listen to webcast

Amendment to the KP415 License Agreement Conference Call

04-08-2021 4:30 PM EDT

Transcript link

33rd Annual Roth Conference

03-15 - 03-17-2021

Listen to webcast

KemPharm Q4 2020 Corporate Update Call

03-11-2021 4:30 PM EST

Listen to webcast

Click here for transcript and audio replay

AZSTARYS™ (KP415) FDA Approval Conference Call

03-03-2021 8:30 AM EST

Listen to webcast

Click here for transcript and audio replay

KP415 Market Opportunity and Commercialization Strategy

12-02-2020 10:00 AM EST

Listen to webcast

Click here for transcript and audio replay

Special Meeting of Stockholders

11-17-2020 8:00 AM EST

KemPharm Q3 2020 Corporate Update Call

10-29-2020 4:30 PM EDT

Listen to webcast

Click here for transcript and audio replay

Virtual Life Science Investor Forum

09-17-2020 10:30 AM EDT

Listen to webcast

Pagination

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Page 5
Next page
Last page

About Us
Our Approach
- What We Do
- Partnering
Patients & Providers
Science & Pipeline
Investors
Careers
- Culture
- Job Openings
Contact
Home

© 2023 Zevra Therapeutics, Inc. All rights reserved. Privacy Policy | Terms of Use